Navigation Links
Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

rget="_blank" href= "http://www.abstracts2view.com/aan2007boston/view.php?nu=AAN07L_P01.046&terms"> http://www.abstracts2view.com/aan2007boston/view.php?nu=AAN07L_P01.046&terms <http://www.abstracts2view.com/aan2007boston/view.php?nu=AAN07L_P01.046&terms> .

Findings of this immunological analysis comparing patients who received either 3 months of induction treatment with mitoxantrone followed by COPAXONE(r) for 12 months or COPAXONE(r) alone for 15 months, was designed to determine whether the improved clinical and MRI outcomes reflect an enhanced capacity for COPAXONE(r)-mediated Th2 shift following immune suppression. Researchers serially measured patients' (n=21) serum for COPAXONE(r)-reactive antibodies (Total IgG: IgG1, IgG2, IgG3, IgG4) by ELISA (enzyme-linked immunosorbant assay). The relationship between IgG1 and IgG4 COPAXONE(r)-reactive antibodies has been determined to be a useful marker of COPAXONE(r)-mediated Th2 shift.

Researchers concluded that induction with mitoxantrone appears to partially reduce and/or delay the IgG1 to IgG4 switch characteristic of the Th2 shift. This information, coupled with MRI measures of disease activity suggest the enhanced efficacy of COPAXONE(r)-mitoxantrone over COPAXONE(r) alone is not due to an enhanced Th2-shift but rather reflects combined anti-inflammatory effects of COPAXONE(r) and mitoxantrone.

About COPAXONE(r)

COPAXONE(r) is indicated for the reduction of the frequency of relapses in RRMS. The most common side effects of COPAXONE(r) are redness, pain, swelling, itching, a lump or an indentation at the site of injection, weakness, infection, pain, nausea, joint pain, anxiety, and muscle stiffness.

COPAXONE(r) is now approved in 47 countries worldwide, including the United States, Canada, Mexico, Australia, Israel, and all European countries. In Europe,
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:7/28/2015)... July 28, 2015 Mike Rowe , spokesperson ... Good Neighbor Pharmacy,s 2015 ThoughtSpot conference ... in Las Vegas, Nev. ... Gotta Do It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe ... nation,s  "unsung heroes" – people whose hard work, sacrifice and ...
(Date:7/28/2015)... N.Y. , July 28, 2015 VirtualScopics, ... clinical trial imaging solutions, today announced that it will ... 4:00 p.m. ET market close on Tuesday, August 11, ... executive officer, and Jim Groff , chief financial ... discuss the company,s financial results and provide a business ...
(Date:7/28/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, announced ... after the market closes on Tuesday, August 4, 2015. ... the same day at 4:30 p.m. ET (1:30 p.m. ... corporate update. The live call may be ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2
... Investment in Vaccine to Prevent Rotavirus, NEW ... that it has purchased a royalty interest in ... an oral,vaccine developed to prevent rotavirus infection, a ... infants and young children.,The product is marketed by ...
... The Public Patent,Foundation ("PUBPAT") announced today that the U.S. ... patents held by Gilead Sciences,that relate to the drug ... in the battle against HIV/AIDS. Gilead markets TDF in,the ... a part of its ATRIPLA,combination product., Roughly 40 ...
Cached Medicine Technology:Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix(R) 2U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims 2
(Date:7/28/2015)... Los Angeles, CA (PRWEB) , ... July 28, ... ... and engineer of patented products, announces Skimmer Helper, a household invention that cleans ... industry is worth $3 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Mindful Her, ... all ages to take their healthy and mindful living practices to the next level, ... and author of Living with Intent as keynote. Global Girls, an Orange County ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... Hospital examines outcomes for inmates who continued methadone maintenance treatment (MMT) during incarceration ... more likely to relapse to opiate use (1) and more likely to require ...
(Date:7/28/2015)... ... July 28, 2015 , ... Darryl Worley’s Annual Tennessee River ... 14th year of raising money for the Darryl Worley Foundation. Worley will host ... main concert Saturday, Oct. 3. , This year’s concert will have a second ...
(Date:7/28/2015)... ... ... 2016, the number of smartphones worldwide will surpass 2 billion. This means that brands ... customer loyalty. However, capitalizing on this is not always obvious. Companies that do not, ... , The Open Mobile Summit 2015 is an influential gathering of mobile visionaries from ...
Breaking Medicine News(10 mins):Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3
... , AUGUSTA, Ga. If you think teenagers prefer social ... at least when it comes to teens involved in research ... counties were asked how they preferred to be contacted about ... , Nearly 54 percent preferred contact via cell ...
... , WEDNESDAY, Aug. 10 (HealthDay News) -- The breast cancer ... patients, especially those with a history of heart disease and/or ... records of 45 women, ages 70 to 92, who were ... (26.7 percent) of them developed heart problems caused by the ...
... , WEDNESDAY, Aug. 10 (HealthDay News) -- Eating ... -- increases your risk of type 2 diabetes, a new ... lower your diabetes risk by replacing red meat with healthier ... Harvard School of Public Health researchers looked at 20 ...
... that many consumers have had so far with the much-heralded ... the current edition of Chemical & Engineering News ... fruits of the science of ultra-small particles so tiny ... hair may come when sunbathers, golfers, bikers and others ...
... University of New Hampshire researcher has discovered that a ... research findings so he could conclude that his Wisconsin ... people. Benjamin Harris, professor of psychology and affiliate ... psychologist Arnold Gesell manipulated the photographic record by selectively ...
... , DETROIT A pharmacist-directed anticoagulation service improves the ... clinic for patients treated with the anticoagulant drug warfarin, ... study, published online today in the July/August issue of ... ,the transition of care directed by the anticoagulation service ...
Cached Medicine News:Health News:Telephone trumps social media when communicating with teens about research 2Health News:Breast Cancer Drug Raises Risk of Heart Problems in Older Women: Study 2Health News:Daily Hot Dog May Feed Diabetes Risk: Study 2Health News:UNH researcher discovers research manipulated to support pro-eugenic beliefs 2Health News:UNH researcher discovers research manipulated to support pro-eugenic beliefs 3Health News:Pharmacist-directed anticoagulation service improves care coordination 2
... The PowerPac HV high-voltage ... V, supports an increased output ... and 400 W. Built-in infrared ... transfer. Power cord and instructions ...
... The PowerPac HC high-current power supply replaces the ... 3.0 A, and 300 W, the PowerPac HC ... the perfect choice for western blotting with any ... with the new Trans-Blot Plus cell for large ...
... SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ): ... less than or equal to 35C Remelt Point (3%): ... greater than or equal to 300 gm/cm 2 ... than or equal to 0.10% DNase: Passes test RNase: ...
... Form: Granular, free-flowing powder EEO(-m r ): less ... less than or equal to 35.5C Remelt Point (3%): ... (1.5%): greater than or equal to 600 gm/cm ... or equal to 1500 gm/cm 2 Moisture: ...
Medicine Products: